Ready-to-Use PCR Panels, 84 miRNA assays targeting the mentioned specific research focus, reference miRNAs and spike-in control assays
96-well format: 4 panel sets (4 plates in total)
384-well format: 8 panel sets (2 plates in total)
96-well format: 4 panel sets (4 plates in total)
384-well format: 8 panel sets (2 plates in total)
Target List
Prostate Cancer Versus Normal Tissue or Benign Prostatic Hyperplasia
Upregulated in Prostate Cancer
hsa-let-7b-5phsa-let-7f-5phsa-miR-106b-5phsa-miR-141-3phsa-miR-148a-3phsa-miR-15b-5phsa-miR-181a-5phsa-miR-182-5phsa-miR-183-5phsa-miR-184hsa-miR-194-5phsa-miR-196a-5phsa-miR-200c-3phsa-miR-20a-5phsa-miR-21-5phsa-miR-218-5phsa-miR-25-3phsa-miR-26a-5phsa-miR-26b-5phsa-miR-32-5phsa-miR-375-3phsa-miR-425-5phsa-miR-96-5p
Downregulated in Prostate Cancer
hsa-let-7a-5phsa-miR-100-5phsa-miR-101-3phsa-miR-125b-5phsa-miR-126-3phsa-miR-126-5phsa-miR-128-3phsa-miR-133a-3phsa-miR-143-3phsa-miR-145-5phsa-miR-17-3phsa-miR-181b-5phsa-miR-203a-3phsa-miR-205-5phsa-miR-223-3phsa-miR-23b-3phsa-miR-27a-3phsa-miR-27b-3phsa-miR-296-5phsa-miR-29b-3phsa-miR-31-5phsa-miR-330-3phsa-miR-34a-5phsa-miR-34b-3phsa-miR-34c-5phsa-miR-449ahsa-miR-494-3phsa-miR-7-5phsa-miR-93-5p
Regulated in Prostate Cancer
hsa-let-7c-5phsa-miR-125a-5phsa-miR-16-5phsa-miR-17-5phsa-miR-22-3phsa-miR-221-3phsa-miR-222-3phsa-miR-24-3phsa-miR-92a-3phsa-miR-99b-5p
Androgen-Independent (Castration Resistant Prostate Cancer) Versus Dependent Cancers
Upregulated in Androgen-Independent Prostate Cancer
hsa-miR-135b-5phsa-miR-15a-5phsa-miR-184hsa-miR-21-5phsa-miR-221-3phsa-miR-30c-5phsa-miR-361-5phsa-miR-455-5phsa-miR-616-3p
Downregulated in Androgen-Independent Prostate Cancer
hsa-miR-100-5phsa-miR-125b-5phsa-miR-128-3phsa-miR-146a-5phsa-miR-146b-5phsa-miR-19b-3phsa-miR-203a-3phsa-miR-23b-3phsa-miR-27b-3phsa-miR-29b-3phsa-miR-331-3phsa-miR-365a-3phsa-miR-99a-5p
Regulated in Androgen-Independent Prostate Cancer
hsa-let-7c-5phsa-miR-135a-5phsa-miR-16-5phsa-miR-17-5phsa-miR-222-3phsa-miR-92a-3phsa-miR-99b-5p
Androgen Receptor-Regulated miRNAs
Upregulated by Androgen Receptor
hsa-miR-148a-3phsa-miR-15b-5phsa-miR-20a-5phsa-miR-20b-5phsa-miR-21-5p
Downregulated by Androgen Receptor
hsa-miR-19b-3phsa-miR-29b-3phsa-miR-93-5p
Regulated by Androgen Receptor
hsa-miR-16-5phsa-miR-17-5p
Perineural Invasion
Upregulated during Perineural Invasion
hsa-miR-15a-5phsa-miR-181a-5phsa-miR-195-5phsa-miR-21-5phsa-miR-224-5phsa-miR-26a-5phsa-miR-30c-5p
Downregulated during Perineural Invasion
hsa-miR-100-5phsa-miR-125b-5phsa-miR-126-3phsa-miR-145-5phsa-miR-27a-3phsa-miR-27b-3p
Regulated during Perineural Invasion
hsa-miR-24-3phsa-miR-99b-5p
Aggressive Versus Non-aggressive Prostate Cancer
Upregulated in Aggressive Prostate Cancer
hsa-miR-9-3p
Downregulated in Aggressive Prostate Cancer
hsa-miR-145-5phsa-miR-221-3phsa-miR-330-3phsa-miR-331-3phsa-miR-34c-5p
Regulated in Aggressive Prostate Cancer
hsa-miR-16-5p
Blood, Plasma & Serum Markers
Upregulated Prostate Cancer Markers
hsa-miR-141-3phsa-miR-200b-3phsa-miR-21-5phsa-miR-375-3phsa-miR-9-3p
Regulated Prostate Cancer Markers
hsa-miR-221-3phsa-miR-26a-5p
Predicted to Target Prostate Cancer Genes
hsa-miR-3163hsa-miR-3662hsa-miR-3666hsa-miR-374b-5p